APOE and early-onset autosomal dominant Alzheimer disease: We here used ApoE−/− mice, a model related to atherosclerosis, Alzheimer’s disease and other vascular diseases, and CNS dysfunction [4,5,10,11,37], and exposed them to a dose of 3 Gy [38], which is relevant to cancer therapy.